Nanotechnology in cardiovascular medicine

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 5, 2007, Pages 643-654

  Patel, Devang N ^a,b   Bailey, Steven R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MC 7872 ^*  (United States)

Author keywords

Drug delivery; Imaging; Nanoparticles; Nanoporous materials; Nanotechnology

Indexed keywords

ALUMINUM OXIDE; CARBON NANOTUBE; DENDRIMER; LIPOSOME; NANOCAPSULE; NANOPARTICLE; QUANTUM DOT;

CARDIOVASCULAR DISEASE; CONTACT ANGLE; DEVICE; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; HUMAN; HYDROPHOBICITY; IMPLANT; INFRARED SPECTROSCOPY; MACROMOLECULE; MICELLE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PARTITION COEFFICIENT; POROSITY; REVIEW; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; SURFACE TENSION; SYSTEMATIC REVIEW; TISSUE ENGINEERING;

ABSORBABLE IMPLANTS; BIOMEDICAL AND DENTAL MATERIALS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; MACROMOLECULAR SUBSTANCES; NANOMEDICINE; NANOSTRUCTURES;

EID: 34147198196     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21060     Document Type: Review

References (58)

1. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001;41:189-207.
2. Panyam J, Lof J, O'Leary E, Labhasetwar V. Efficiency of dispatch and infiltrator cardiac infusion catheters in arterial localization of nanoparticles in a porcine coronary model of restenosis. J Drug Target 2002;10:515-523.
3. Guzman LA, Labhasetwar V, Song C, Jang Y, Lincoff AM, Levy R, Topol EJ. Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 1996;94:1441-1448.
4. Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation 2002;106:2842-2847.
5. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20.
6. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55:329-347.
7. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J 2002;16: 1217-1226.
8. Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm 2004;1:77-84.
9. Jain TK, Roy I, De TK, Maitra A. Nanometer silica particles encapsulating active compounds: A novel ceramic drug carrier. J Am Chem Soc 1998;120:11092-11095.
10. Roy I, Mitra S, Maitra A, Mozumdar S. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int J Pharm 2003;250:25-33.
11. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003;125:7860-7865.
12. Cherian AK, Rana AC, Jain SK. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 2000;26:459-463.
13. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-131.
14. Rosler A, Vandermeulen GW, Klok HA. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev 2001;53:95-108.
15. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. Block copolymer micelles: Preparation, characterization and application in drug delivery. J Control Release 2005; 109:169-188.
16. Jones M, Leroux J. Polymeric micelles - A new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48:101-111.
17. Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Development of the polymer micelle carrier system for doxorubicin. J Control Release 2001;74:295-302.
18. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 2004;61:2549-2559.
19. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001;73:137-172.
20. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-160.
21. Gabizon A, Goren D, Cohen R, Barenholz Y. Development of liposomal anthracyclines: From basics to clinical applications. J Control Release 1998;53:275-279.
22. Heeremans JL, Prevost R, Bekkers ME, Los P, Emeis JJ, Kluft C, Crommelin DJ. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: A comparison with free t-PA. Thromb Haemost 1995;73:488-494.
23. Svenson S, Tomalia DA. Dendrimers in biomedical applications - Reflections on the field. Adv Drug Deliv Rev 2005;57: 2106-2129.
24. Yang H, Kao WJ. Dendrimers for pharmaceutical and biomedical applications. J Biomater Sci Polym Ed 2006;17:3-19.
25. Smith AM, Ruan G, Rhyner MN, Nie S. Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann Biomed Eng 2006;34:3-14.
26. Yu WW, Chang E, Drezek R, Colvin VL. Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Commun 2006;348:781-786.
27. Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005;100: 1-11.
28. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26:3995-4021.
29. Yu X, Song SK, Chen J, Scott MJ, Fuhrhop RJ, Hall CS, Gaffney PJ, Wickline SA, Lanza GM. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000;44:867-872.
30. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 2001;104: 1280-1285.
31. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415-422.
32. Cui Y, Wei Q, Park H, Lieber CM. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 2001;293:1289-1292.
33. McKendry R, Zhang J, Arntz Y, Strunz T, Hegner M, Lang HP, Bailer MK, Certa U, Meyer E, Guntherodt HJ, Gerber C. Multiple label-free biodetection and quantitative DNA-binding assays on a nanomechanical cantilever array. Proc Natl Acad Sci USA 2002; 99:9783-9788.
34. Arntz Y, Seelig JD, Lang HP, Zhang J, Hunziker P, Ramseyer JP, Meyer E, Hegner M, Gerber C. Label-free protein assay based on a nanomechanical cantilever array. Nanotechnology 2003;14:86-90.
35. Sinha N, Yeow JT. Carbon nanotubes for biomedical applications. IEEE Trans Nanobiosci 2005;4:180-195.
36. Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005;9:674-679.
37. Park KH, Chhowalla M, Iqbal Z, Sesti F. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 2003;278:50212-50216.
38. Geho D, Cheng MM, Killian K, Lowenthal M, Ross S, Frogale K, Nijdam J, Lahar N, Johann D, Herrmann P, Whiteley G, Ferrari M, Petricoin E, Liotta L. Fractionation of serum components using nanoporous substrates. Bioconjug Chem 2006;17: 654-661.
39. El-Ghannam A, Ahmed K, Omran M. Nanoporous delivery system to treat osteomyelitis and regenerate bone: Gentamicin release kinetics and bactericidal effect. J Biomed Mater Res B Appl Biomater 2005;73:277-284.
40. Wieneke H, Dirsch O, Sawitowski T, Gu YL, Brauer H, Dahmen U, Fischer A, Wnendt S, Erbel R. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc Interv 2003;60:399-407.
41. Kollum M, Farb A, Schreiber R, Terfera K, Arab A, Geist A, Haberstroh J, Wnendt S, Virmani R, Hehrlein C. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Catheter Cardiovasc Interv 2005;64:85-90.
42. Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: Evaluation in a porcine model. Catheter Cardiovas Interv 2006;67:698-702.
43. Erlebacher J, Aziz MJ, Karma A, Dimitrov N, Sieradzki K. Evolution of nanoporosity in dealloying. Nature 2001;410:450-453.
44. 2 films. Biomed Mater 2006;1:L11-L15.
45. Ayon A, Agrawal CM, Cantu M, Feldman MD, Johnson DM, Marton D, Patel DN, Shi E. Characterization of nanoporous titanium dioxide films for biomedical applications. Transactions of the 31st Annual Meeting of the Society for Biomaterials, April, 2006, Pittsburgh, PA.
46. Ayon A, Agrawal CM, Chava K, Feldman MD, Johnson D, Patel DN. Utilization of nanoporous titanium dioxide films on drug eluting stents. Transactions of the 31st Annual Meeting of the Society for Biomaterials, April, 2006, Pittsburgh, PA.
47. Nishizawa M, Menon VP, Martin CR. Metal nanotubule membranes with electrochemically switchable ion-transport selectivity. Science 1995;268:700-702.
48. Cornell BA, Braach-Maksvytis VL, King LG, Osman PD, Raguse B, Wieczorek L, Pace RJ. A biosensor that uses ion-channel switches. Nature 1997;387:580-583.
49. Vercoutere W, Winters-Hilt S, Olsen H, Deamer D, Haussler D, Akeson M. Rapid discrimination among individual DNA hairpin molecules at single-nucleotide resolution using an ion channel. Nat Biotechnol 2001;19:248-252.
50. Birge RR. Protein-Based Computers, Vol. 272. Scientific American; 1995. 0036-8733.
51. Ulman A. Formation and structure of self-assembled monolayers. Chem Rev 1996;96:1533-1554.
52. Senaratne W, Andruzzi L, Ober CK. Self-assembled monolayers and polymer brushes in biotechnology: Current applications and future perspectives. Biomacromolecules 2005;6:2427-2448.
53. Johnson MD, Mahapatro A, Patel DN, Feldman MD, Ayon A. The use of alkanethiol self-assembled monolayers (SAMs) on 316L stainless steel for coronary artery stent nanomedicine applications: An oxidative and in vitro stability study. Nanomed Nanotechnol Biol Med 2006;2:182-190.
54. Mahapatro A, Johnson DM, Patel DN, Feldman MD, Ayon AA, Agrawal CM. Surface modification of functional self-assembled monolayers on 316L stainless steel via lipase catalysis. Langmuir 2006;22:901-905.
55. Mani G, Johnson DM, Marton D, Mahapatro A, Feldman MD, Ayon A, Patel DN, Agrawal CM. Drug elution using therapeutic self-assembled monolayers. Transactions of the 31st Annual Meeting of the Society For Biomaterials, Vol. 29, April, 2006, Abst No 307.
56. Mani G, Johnson D, Marton D, Mahapatro A, Feldman MD, Patel DN, Ayon A, Agrawal CM. Stability of therapeutic self assembled monolayers during drug loading and in-vitro drug delivery. Transactions of the 31st Annual Meeting of the Society for Biomaterials, Vol. 29, April, 2006, Abst No 327.
57. Mahapatro M, Johnson D, Mani G, Patel DN, Feldman MD, Ayon A, Agrawal CM. Preparation and characterization of functional self assembled monolayers (SAMs) on 316L stainless steel, 230th American Chemical Society National Meeting, January, 2005, Washington, DC.
58. Freitas RA Jr. Exploratory design in medical nanotechnology: A mechanical artificial red cell. Artif Cells Blood Substit Immobil Biotechnol 1998;26:411-430.